DK1827136T3 - Sammensætning til oral indgivelse med sundhedsfremmende virkning på hjerte-kredslöbs-systemet - Google Patents
Sammensætning til oral indgivelse med sundhedsfremmende virkning på hjerte-kredslöbs-systemetInfo
- Publication number
- DK1827136T3 DK1827136T3 DK05792107T DK05792107T DK1827136T3 DK 1827136 T3 DK1827136 T3 DK 1827136T3 DK 05792107 T DK05792107 T DK 05792107T DK 05792107 T DK05792107 T DK 05792107T DK 1827136 T3 DK1827136 T3 DK 1827136T3
- Authority
- DK
- Denmark
- Prior art keywords
- composition
- oral administration
- cardiovascular system
- promoting effect
- health promoting
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 230000008821 health effect Effects 0.000 title abstract 3
- 210000000748 cardiovascular system Anatomy 0.000 title abstract 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 abstract 2
- UOTMYNBWXDUBNX-UHFFFAOYSA-N 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinolin-2-ium;chloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 UOTMYNBWXDUBNX-UHFFFAOYSA-N 0.000 abstract 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 abstract 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 abstract 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 235000013793 astaxanthin Nutrition 0.000 abstract 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 abstract 1
- 229940022405 astaxanthin Drugs 0.000 abstract 1
- 239000001168 astaxanthin Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 235000017471 coenzyme Q10 Nutrition 0.000 abstract 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 abstract 1
- 229940110767 coenzyme Q10 Drugs 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 210000003038 endothelium Anatomy 0.000 abstract 1
- 235000019152 folic acid Nutrition 0.000 abstract 1
- 229960000304 folic acid Drugs 0.000 abstract 1
- 239000011724 folic acid Substances 0.000 abstract 1
- 229940057059 monascus purpureus Drugs 0.000 abstract 1
- 229960001109 policosanol Drugs 0.000 abstract 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/60—Edible seaweed
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B67/00—Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
- C09B67/0097—Dye preparations of special physical nature; Tablets, films, extrusion, microcapsules, sheets, pads, bags with dyes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medical Informatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Marine Sciences & Fisheries (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000682A ITTO20040682A1 (it) | 2004-10-07 | 2004-10-07 | Formulazione per somministrazione orale avente un effetto salutistico sull'apparato cardiovascolare |
| PCT/EP2005/054691 WO2006037725A1 (en) | 2004-10-07 | 2005-09-20 | Formulation for oral administration having a health-promoting effect on the cardiovascular system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1827136T3 true DK1827136T3 (da) | 2008-09-15 |
Family
ID=35395774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05792107T DK1827136T3 (da) | 2004-10-07 | 2005-09-20 | Sammensætning til oral indgivelse med sundhedsfremmende virkning på hjerte-kredslöbs-systemet |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20080102082A1 (da) |
| EP (1) | EP1827136B1 (da) |
| AT (1) | ATE397389T1 (da) |
| CY (1) | CY1108314T1 (da) |
| DE (1) | DE602005007380D1 (da) |
| DK (1) | DK1827136T3 (da) |
| ES (1) | ES2308550T3 (da) |
| IT (1) | ITTO20040682A1 (da) |
| PL (1) | PL1827136T3 (da) |
| PT (1) | PT1827136E (da) |
| SI (1) | SI1827136T1 (da) |
| TW (1) | TWI359667B (da) |
| WO (1) | WO2006037725A1 (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI323312B (en) * | 2005-06-23 | 2010-04-11 | Honda Motor Co Ltd | Gas-liquid separation device of engine |
| ITTO20060239A1 (it) | 2006-03-30 | 2007-09-30 | Rotthapharm S P A | Formulazione per somministrazione orale con effetti salutistici sull'apparato cardiovascolare |
| US20100119600A1 (en) | 2007-06-01 | 2010-05-13 | Joar Opheim | Substances for reducing occurrence of major cardiac events comprising red yeast rice extract and omega-3 polyunsaturated fatty acid or derivative thereof |
| US20120171285A1 (en) * | 2007-06-01 | 2012-07-05 | Opheim Joar A | Substances for reducing occurrence of major cardiac events comprising omega-3 polyunsaturated fatty acid or derivatives thereof and high-monacolin k content red yeast rice extract |
| FR2950061B1 (fr) | 2009-09-11 | 2013-12-20 | Coatex Sas | Monomeres associatifs a base de polycosanols, epaississants associatifs correspondants et leurs utilisations |
| ITMI20121696A1 (it) * | 2012-10-09 | 2014-04-10 | Ddf Group S A S | Composizioni per il trattamento delle iperlipidemie |
| ITUB20150541A1 (it) | 2015-03-03 | 2016-09-03 | Acraf | Composizione comprendente sostanze e/o estratti naturali |
| CN105878801A (zh) * | 2016-05-10 | 2016-08-24 | 胡铭 | 一种具有降血脂作用的红曲虾青素组合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5952393A (en) * | 1998-02-12 | 1999-09-14 | Sorkin, Jr.; Harlan Lee | Composition for reducing serum cholesterol levels |
| US20030104090A1 (en) * | 2000-05-05 | 2003-06-05 | Levy Pedro E. | Supplements containing annatto extracts and carotenoids and methods for using the same |
| US6436406B1 (en) * | 2000-06-15 | 2002-08-20 | A. Glenn Braswell | Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis |
| US6300377B1 (en) * | 2001-02-22 | 2001-10-09 | Raj K. Chopra | Coenzyme Q products exhibiting high dissolution qualities |
| WO2003020260A1 (en) * | 2001-08-31 | 2003-03-13 | Metaproteomics, Llc | Arginine compositions for coordinate modification of multiple cardiovascular risk factors |
-
2004
- 2004-10-07 IT IT000682A patent/ITTO20040682A1/it unknown
-
2005
- 2005-09-20 WO PCT/EP2005/054691 patent/WO2006037725A1/en active IP Right Grant
- 2005-09-20 ES ES05792107T patent/ES2308550T3/es active Active
- 2005-09-20 DE DE602005007380T patent/DE602005007380D1/de active Active
- 2005-09-20 PT PT05792107T patent/PT1827136E/pt unknown
- 2005-09-20 SI SI200530379T patent/SI1827136T1/sl unknown
- 2005-09-20 AT AT05792107T patent/ATE397389T1/de active
- 2005-09-20 US US11/576,644 patent/US20080102082A1/en not_active Abandoned
- 2005-09-20 EP EP05792107A patent/EP1827136B1/en not_active Not-in-force
- 2005-09-20 DK DK05792107T patent/DK1827136T3/da active
- 2005-09-20 PL PL05792107T patent/PL1827136T3/pl unknown
- 2005-10-05 TW TW094134749A patent/TWI359667B/zh active
-
2008
- 2008-09-03 CY CY20081100945T patent/CY1108314T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI1827136T1 (sl) | 2008-12-31 |
| WO2006037725A1 (en) | 2006-04-13 |
| CY1108314T1 (el) | 2014-02-12 |
| DE602005007380D1 (de) | 2008-07-17 |
| EP1827136B1 (en) | 2008-06-04 |
| PT1827136E (pt) | 2008-09-09 |
| ES2308550T3 (es) | 2008-12-01 |
| ATE397389T1 (de) | 2008-06-15 |
| PL1827136T3 (pl) | 2008-11-28 |
| EP1827136A1 (en) | 2007-09-05 |
| US20080102082A1 (en) | 2008-05-01 |
| TW200621272A (en) | 2006-07-01 |
| TWI359667B (en) | 2012-03-11 |
| ITTO20040682A1 (it) | 2005-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1108314T1 (el) | Σκευασμα για στοματικη χορηγηση εχοντας μια δραση που προαγει την υγεια επι του καρδιαγγειακου συστηματος | |
| DK2007429T3 (da) | Oralt præparat med gavnlige cardiovaskulære virkninger indeholdende berberin | |
| WO2008128049A3 (en) | Tetrahydrobiopterin compositions and methods of measuring | |
| WO2006068697A3 (en) | Compositions including iron | |
| MY143795A (en) | Tetrahydropyridoindole derivatives | |
| WO2007093624A3 (en) | Pharmaceutical compositions for the treatment of attention deficit hyperactivity disorder comprising flibanserin | |
| GB2459809A (en) | Fatty acid formulations and methods of use thereof | |
| SG10201406300YA (en) | L-ornithine phenyl acetate and methods of making thereof | |
| SG194679A1 (en) | Composition useful for the treatment of lipid metabolism disorders | |
| BR112012019190A2 (pt) | composições de cuidado oral. | |
| WO2010041832A3 (ko) | 패 유래 화합물 함유 항산화 활성 조성물 | |
| MX2019009952A (es) | Formulaciones de evolocumab de baja viscosidad y alta concentracion y metodos de elaboracion de las mismas. | |
| PL1708711T3 (pl) | Kompozycje użyteczne zwłaszcza w leczeniu lub zapobieganiu zespołowi metabolicznemu | |
| EP1897539A4 (en) | COMPOSITION AGAINST TIREDNESS | |
| JP2010275318A5 (da) | ||
| WO2014082027A3 (en) | Antioxidant dietary supplement | |
| HK1117751A1 (en) | Dental enamel recalcification accelerator and containing the same, oral composition and food or beverage | |
| MX342417B (es) | Composicion antioxidante para reducir el estres oxidativo atribuible al tratamiento con farmacos anticonceptivos hormonales. | |
| WO2011141113A3 (de) | Kombination aus vitamin k und nikotinamid | |
| WO2016014680A3 (en) | Oral transmucosal compositions including aromatase inhibitors for low testosterone levels in men | |
| RS20050901A (en) | Indole derivatives with apoptosis- inducing effect | |
| WO2012091425A3 (ko) | 4-하이드록시 타목시펜 유사체 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는, 대사증후군 관련 질환의 예방 또는 치료용 조성물 | |
| WO2014145086A3 (en) | Products and methods using lunasin-enriched soy extract mixtures | |
| WO2008084762A1 (ja) | テアニン含有神経細胞新生促進組成物 | |
| MY160626A (en) | Composition for amelioration of hypoalbuminemia |